Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment

By sjmartinez • August 22, 2024

Parikh UM, Heaps AL, Moisi D, Gordon KC, Mellors JW, Choudhary MC, Deo R, Moser C, Klekotka P, Landay AL, Currier JS, Eron JJ, Chew KW, Smith DM, Li JZ, Sieg SF; Team ACTIV-2/A5401 Study. Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody Treatment. Pathog Immun. 2024 Aug 15;9(2):58-78. doi: 10.20411/pai.v9i2.715. PMID: 39165724; PMCID: PMC11335343.

Tags: bamlanivimab, Bio-Plex, Covid, covid-19, Infectious Diseases, Meso Scale Discovery, Monoclonal antibodies, Publications, SARS-CoV-2

Political engagement: a key pillar in revitalisation of polio and routine immunisation programmes in the Democratic Republic of the Congo

Kamba R, El Mourid A, Mpoyi Ngambwa R, Chungu Salumu D, Le Gargasson JB, Nacoulma D, Nimpa Mengouo M, Meyer N, Luhata C, Hoff NA,[...]

Effects of Pitavastatin on COVID-19 Incidence and Seriousness Among a Global Cohort of People With HIV

Zanni MV, Umbleja T, Fichtenbaum CJ, Fitch KV, McCallum S, Aberg JA, Overton ET, Malvestutto CD, Bloomfield GS, Currier JS, Schnittman SR, Erlandson KM, Diggs[...]

Clostridium paraputrificum in a Middle-Aged Male With Liver Disease

Dao KT, D'Assumpcao C, Sharma R, Heidari A. Clostridium paraputrificum in a Middle-Aged Male With Liver Disease. J Investig Med High Impact Case Rep. 2024 Jan-Dec;12:23247096241292213. doi:[...]